PPBT - MCAP CO - Purple Biotech

Purple Biotech (PPBT) develops biopharmaceuticals to combat malignant tumor resistance, leveraging international patents. The company's innovations are based on identifying methods for the targeted destruction of pathogenic cells. This price chart reflects a market capitalization that currently stands at 0.00. Growth prospects depend on clearing FDA filters and confirming high therapeutic efficacy in clinical trials.

Purple Biotech acts as an innovative player in the biopharmaceutical sector, developing advanced methods to combat tumor resistance. By analyzing fluctuations in the company's market capitalization, an investor can observe the dynamics of the total business value. This figure is calculated by multiplying the current share price by the total number of outstanding securities. This metric reflects the market consensus regarding the value of all assets and intellectual property. High scientific potential in oncology makes this indicator a key measure of the enterprise's fundamental value.